PT Kalbe Farma Tbk. (PTKFF)

USD 0.1

(0.0%)

Operating Expenses Summary of PT Kalbe Farma Tbk.

  • PT Kalbe Farma Tbk.'s latest annual operating expenses in 2023 was 11823.24 Billion USD , up 11.77% from previous year.
  • PT Kalbe Farma Tbk.'s latest quarterly operating expenses in 2024 Q3 was 148.53 Million USD , up 2533438.72% from previous quarter.
  • PT Kalbe Farma Tbk. reported a annual operating expenses of 456.21 Million USD in annual operating expenses 2022, down -5.79% from previous year.
  • PT Kalbe Farma Tbk. reported a annual operating expenses of 484.27 Million USD in annual operating expenses 2021, up 6.74% from previous year.
  • PT Kalbe Farma Tbk. reported a quarterly operating expenses of 148.53 Million USD for 2024 Q3, up 2533438.72% from previous quarter.
  • PT Kalbe Farma Tbk. reported a quarterly operating expenses of 126.48 Million USD for 2024 Q1, up 4.68% from previous quarter.

Annual Operating Expenses Chart of PT Kalbe Farma Tbk. (2023 - 2015)

Historical Annual Operating Expenses of PT Kalbe Farma Tbk. (2023 - 2015)

Year Operating Expenses Operating Expenses Growth
2023 11823.24 Billion USD 11.77%
2022 456.21 Million USD -5.79%
2021 484.27 Million USD 6.74%
2020 453.69 Million USD -5.44%
2019 479.8 Million USD 7.82%
2018 445 Million USD -5.41%
2017 470.46 Million USD 0.89%
2016 466.3 Million USD 10.59%
2015 421.65 Million USD 0.0%

Peer Operating Expenses Comparison of PT Kalbe Farma Tbk.

Name Operating Expenses Operating Expenses Difference
AstraZeneca PLC 29.57 Billion USD -39873.107%
Bristol-Myers Squibb Company PFD CONV 2 17.07 Billion USD -69159.244%
CSPC Pharmaceutical Group Limited 2.14 Billion USD -550596.598%
Clarus Therapeutics Holdings, Inc. 50.96 Million USD -23196834.477%
Novartis AG 24.87 Billion USD -47438.28%